Indian Journal of Nuclear Medicine
Home | About IJNM | Search | Current Issue | Past Issues | Instructions | Ahead of Print | Online submissionLogin 
Indian Journal of Nuclear Medicine
  Editorial Board | Subscribe | Advertise | Contact
Users Online: 575 Print this page  Email this page Small font size Default font size Increase font size
EDITORIAL
Year : 2017  |  Volume : 32  |  Issue : 1  |  Page : 11-12

Specificity of 68Ga-PSMA PET/CT for prostate cancer - myths and reality


Consultant Nuclear Medicine and PET/CT, KIMS-DDNMRC, KIMS hospital North Block, Anayara P.O, Thiruvananthapuram, Kerala, India

Correspondence Address:
Arun Sasikumar
Consultant Nuclear Medicine and PET/CT, KIMS-DDNMRC, KIMS hospital North Block, Anayara P.O, Thiruvananthapuram, Kerala
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/0972-3919.198449

Rights and Permissions

68Ga-PSMA ligand PET/CT for imaging prostate cancer is a novel imaging technique, which is rapidly gaining popularity. Sufficient evidence has been accumulated in literature regarding the usefulness of 68Ga-PSMA PET/CT in prostate cancer. Recently literature regarding the localization of 68Ga-PSMA PET/CT imaging in non-prostatic malignancies is also published, thus questioning the specificity of the tracer with regards to prostate cancer. This commentary tries to address the issue of specificity of 68Ga-PSMA PET/CT and its relevance in imaging prostate cancer.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed3889    
    Printed24    
    Emailed0    
    PDF Downloaded367    
    Comments [Add]    

Recommend this journal